Conversion of Convertible Loan Notes

AI SummaryClose X

Cizzle Biotechnology Holdings PLC announced the conversion of £400,000 of convertible loan notes into 28,571,429 new ordinary shares at a price of 1.4 pence per share, with admission expected around May 11, 2026. The company has also drawn down £100,000 from a new facility, leaving £100,000 of convertible loan notes outstanding. Following these transactions, Cizzle Biotechnology will have 424,963,202 ordinary shares in issue, representing the total voting rights.

Disclaimer*

UK 100

Latest directors dealings